Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-02-21
2006-02-21
Lewis, Patrick (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S054000, C426S641000, C426S644000, C426S645000, C426S658000, C426S516000, C426S518000, C536S124000, C536S127000
Reexamination Certificate
active
07001894
ABSTRACT:
Glucosamine salts and derivatives are effective for the improvement of blood flow, and hence, for the prevention and/or treatment of diseases caused by blood flow disturbances, such as thrombosis. Use of glucosamine salts or glucosamine derivatives as active ingredients can provide blood flow improvers, thrombosis preventives or remedies, and dietetic drinks or foods for the improvement of blood flow or for the prevention and/or treatment of thrombosis. Administration of glucosamine salts or glucosamine derivatives can improve blood flow and can prevent and/or treat thrombosis.
REFERENCES:
patent: 3697652 (1972-10-01), Rovati et al.
patent: 5155110 (1992-10-01), Connor et al.
patent: 5922692 (1999-07-01), Marino
patent: 6004583 (1999-12-01), Plate et al.
patent: 6037333 (2000-03-01), Panjwani
patent: 6071532 (2000-06-01), Chaikof et al.
patent: 6171614 (2001-01-01), Chaikof et al.
patent: 6399093 (2002-06-01), Petrus
patent: 2473887 (1981-07-01), None
patent: WO 98/52576 (1998-11-01), None
The Merck Index, 1996, 4685.
McCarty, Medical Hypotheses, 1997, 48, 245-251.
The Merck Index, 1996, 4466.
M.F. McCarty, “Glucosamine May Retard Atherogenesis by Promoting Endothelial Production of Heparan Sulfate Proteoglycans”, Medical Hypotheses, (1997), 48, pp. 245-251, XP-001034746.
C.J. Meininger, et al., “Glucosamine Inhibits Inducible Nitric Oxide Synthesis”, Biochemical and Biophysical Research Communications, 279, (2000), pp. 234-239, XP-001041379.
J. Schmidt, et al., “Etiology and Pathophysiology of Acute Pancreatitis”, Ther Umsch, 53(5), May 1996, pp. 322-332, English Abstract Only.
V.G. Naumov, et al., “Blood Rheologic Properties in Patients with Dilated Cardiomyopathy”, Bjull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR, 11(2), 1998, pp. 9-12, English Abstract Only.
S. Forconi, et al., “Haemorheological Disturbances and Possibility of their Correction in Cerebrovascular Diseases”, J Mal Vasc, 24(2), May 1999, pp. 110-116, English Abstract Only.
Saito Tatsuji
Sakamoto Koji
Dainichiseika Color & Chemicals Mfg. Co. Ltd.
Lewis Patrick
Oblon, Spivak, McCelland, Maier & Neustadt, P.C.
LandOfFree
Blood flow improvers and thrombosis preventives or remedies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood flow improvers and thrombosis preventives or remedies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood flow improvers and thrombosis preventives or remedies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646234